Michelle J Henderson Selected Research

Member 1 Subfamily B ATP Binding Cassette Transporter

1/2016	ABC transporters as mediators of drug resistance and contributors to cancer cell biology.
9/2014	High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle J Henderson Research Topics

Disease

15	Neoplasms (Cancer) 02/2024 - 01/2010
9	Neuroblastoma 04/2021 - 08/2011
8	Leukemia 02/2024 - 07/2016
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2007
3	Ovarian Epithelial Carcinoma 04/2022 - 07/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 08/2003
3	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2003
2	Rheumatoid Arthritis 02/2024 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2020 - 08/2010
2	Carcinogenesis 11/2019 - 01/2010
1	Alcoholism (Alcohol Abuse) 02/2024
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Residual Neoplasm 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Multiple Myeloma 01/2020
1	Wounds and Injuries (Trauma) 08/2011
1	Carcinoma (Carcinomatosis) 12/2007
1	Polyploidy 12/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017 - 01/2010
4	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 01/2012
4	Adenosine Triphosphate (ATP)IBA 10/2020 - 08/2011
3	CBLC137IBA 01/2022 - 01/2020
2	Auranofin (Ridaura)FDA Link 02/2024 - 01/2021
2	CholesterolIBA 04/2022 - 07/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2021
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2021
2	PanobinostatIBA 01/2022 - 01/2021
2	ChromatinIBA 01/2022 - 01/2021
2	Drug CombinationsIBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2020
2	OT-82IBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2017 - 08/2003
2	multidrug resistance-associated protein 1IBA 01/2016 - 09/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 09/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2010 - 12/2007
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2024
1	Disulfiram (Antabuse)FDA Link 02/2024
1	Etoposide (VP 16)FDA LinkGeneric 02/2024
1	EnzymesIBA 04/2021
1	PolyaminesIBA 04/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 04/2021
1	blinatumomabIBA 01/2021
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	RNA Helicases (RNA Helicase)IBA 01/2021
1	AntimetabolitesIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020
1	Long Noncoding RNAIBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 11/2019
1	N-Myc Proto-Oncogene ProteinIBA 11/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	taxaneIBA 02/2016
1	PlatinumIBA 02/2016
1	ceefourin 1IBA 09/2014
1	ceefourin 2IBA 09/2014
1	LipidsIBA 07/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014
1	Subfamily A ATP Binding Cassette TransporterIBA 07/2014
1	Small Interfering RNA (siRNA)IBA 08/2011
1	reversanIBA 08/2011
1	Phosphotransferases (Kinase)IBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2010
4	Drug Therapy (Chemotherapy) 02/2024 - 07/2007
1	Combined Modality Therapy 01/2021
1	Immunotherapy 01/2021
1	Transplantation 01/2021
1	Cytoreduction Surgical Procedures 02/2016
1	Remission Induction 07/2007